Jim Cramer on Johnson & Johnson: “It’s a Textbook Slowdown Stock”

2 weeks ago 8

Syeda Seirut Javed

Sat, March 21, 2026 astatine 11:31 AM CDT 2 min read

Johnson & Johnson (NYSE:JNJ) is 1 of the stocks mentioned during the show, arsenic we screen everything Jim Cramer said astir the oversold market. Cramer was rather bullish connected the company’s stock, arsenic helium stated:

Yesterday, we got immoderate terrific quality from Johnson & Johnson, but due to the fact that the portion was truthful ugly, the banal did nothing. Actually finished the league down 0.35%. Oh, it was a brutal session… Sometimes, a terrible, horrible, nary good, precise atrocious time for the averages creates buying opportunities for you, and I deliberation we’re getting 1 close present successful Johnson & Johnson. Why? Because yesterday morning, we learned that they got FDA support for ICOTYDE. Now, that is their oral attraction for mean to terrible plaque psoriasis…

Photo by Artem Podrez connected Pexels

Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and aesculapian technologies, with treatments successful immunology, oncology, neuroscience, cardiovascular care, and infectious diseases.

While we admit the imaginable of JNJ arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article